Taiwan News
Date: 2016-09-02
By: Matthew Strong, Taiwan News, Staff Writer

TAIPEI (Taiwan News) – OBI Pharma Inc. Chairman Michael Chang appeared for questioning by prosecutors Friday as the investigation into the alleged insider trading case which brought down a president of the Academia Sinica was reportedly close to completion.

Wong Chi-huey, the head of Taiwan’s most prestigious research body, saw his resignation approved last May after allegations that he had knowledge about negative test results of a new cancer drug from OBI Pharma and went on to sell shares owned by his daughter before the announcement. Wong maintained his innocence, but the allegations led to his resignation before the end of ten years at the helm of the Academia Sinica.

Chang, who was banned from leaving the country after his release on bail of NT$1 million (US$31,000), was seen at the Shilin District Prosecutors Office in the company of an attorney Friday afternoon.

The media speculated that prosecutors were reaching the end of their investigation and would soon announce whether charges would be forthcoming.     [FULL  STORY]